Michael D. Blaszyk
CIK: 0001371407
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IBRX
ImmunityBio, Inc.
Director
Discretionary Trading P&L
Holdings
About BLASZYK MICHAEL D
BLASZYK MICHAEL D (SEC CIK 0001371407) files insider reports with the SEC as Director of ImmunityBio, Inc. (IBRX).
Signal8 holds 2 ownership filings by BLASZYK MICHAEL D, all Form 4s, filed between Jun 20, 2025 and Jun 10, 2026. Those filings report 2 transactions, from Jun 18, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BLASZYK MICHAEL D's filings is in SAN DIEGO, CA.
Recent filings by BLASZYK MICHAEL D
Other insiders filing for ImmunityBio, Inc. (IBRX)
- Simon Barry J., Director
- Cohen Cheryl, Director
- Selecky Christobel, Director
- Wendel Bruce, Director
- MAXWELL LINDA, Director
- Clark Wesley, Director